Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial.

[1]  R. Labianca,et al.  Randomized phase III trial comparing infused irinotecan/5-fluorouracil (5-FU)/folinic acid (IF) versus 5-FU/FA (F) in stage III colon cancer patients (pts). (PETACC 3) , 2005 .

[2]  Armando Santoro,et al.  Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. , 2004, The New England journal of medicine.

[3]  J. Berlin,et al.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.

[4]  T. Hickish,et al.  Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. , 2004, The New England journal of medicine.

[5]  R. Labianca,et al.  Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinoma. , 2004, Journal of the National Cancer Institute.

[6]  Neal J Meropol,et al.  Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Buyse,et al.  Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  N. Kemeny,et al.  An update on hepatic arterial infusion chemotherapy for colorectal cancer. , 2003, The oncologist.

[9]  W. Scheithauer,et al.  Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  C. Twelves.  Capecitabine as first-line treatment in colorectal cancer. Pooled data from two large, phase III trials. , 2002, European journal of cancer.

[11]  A. Witkamp,et al.  Intraperitoneal chemotherapy for colorectal cancer , 2002, Journal of surgical oncology.

[12]  T. Wiggers,et al.  Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III , 2001, British Journal of Cancer.

[13]  H. Beger,et al.  Toxicity and effects of adjuvant therapy in colon cancer: results of the german prospective, controlled randomized multicenter trial fogt-1 , 2001, Journal of Gastrointestinal Surgery.

[14]  R. Porschen,et al.  Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  S. Marsoni.  Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancer. International Multicenter Pooled Analysis of Colon Cancer Trials Investigators. , 2001, Seminars in oncology.

[16]  N. Wolmark,et al.  National Surgical Adjuvant Breast and Bowel Project trials in colon cancer. , 2001, Seminars in oncology.

[17]  D. Kerr,et al.  Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: non-randomised comparison of weekly versus four-weekly schedules--less pain, same gain. QUASAR Colorectal Cancer Study Group. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  D. Kerr,et al.  Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial , 2000, The Lancet.

[19]  B. Nordlinger,et al.  Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: A multicenter phase III trial. , 2000, Annals of surgery.

[20]  H. Rockette,et al.  Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  W. Scheithauer,et al.  Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma. , 1998, British Journal of Cancer.

[22]  M. Kahn,et al.  Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  R. Peto,et al.  Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. Liver Infusion Meta-analysis Group. , 1997, Journal of the National Cancer Institute.

[24]  H. Wieand,et al.  Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  J. P. Pignon,et al.  Efficacy of adjuvant fluorouracil and folinic acid in colon cancer International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators , 1995, The Lancet.

[26]  C. Tangen,et al.  Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report , 1995, Annals of Internal Medicine.

[27]  H. Rockette,et al.  The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  T R Fleming,et al.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. , 1990, The New England journal of medicine.

[29]  H. Rockette,et al.  Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. , 1988, Journal of the National Cancer Institute.

[30]  E. Grundmann,et al.  Haematogenous metastastic patterns in colonic carcinoma: An analysis of 1541 necropsies , 1986 .

[31]  I. Barofsky,et al.  Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. , 1985, Surgery.

[32]  D. Machin,et al.  A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer , 1985, The British journal of surgery.

[33]  P. Sugarbaker,et al.  Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. , 1981, Cancer research.